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Abstract 
A high proportion of individuals with body dysmorphic disorder (BDD) undergo cosmetic 
treatments in an attempt to ‘fix’ perceived defect/s in their physical appearance. Despite the 
frequency with which such procedures are sought, few studies have prospectively examined 
the outcomes of cosmetic procedures in individuals with BDD. This article aims to critically 
review the literature and discuss the current debate that exists on outcomes of cosmetic 
treatment for individuals with BDD. An emerging literature suggests the majority of 
individuals with BDD have poor outcomes after cosmetic interventions; however, based on 
the current literature, it cannot be fully ruled out that certain individuals with mild BDD and 
localised appearance concerns may benefit from these interventions. Gaps in the current 
literature are highlighted, alongside recommendations for future research. Carefully 
conducted longitudinal studies with well-characterized patient populations are needed. 
 
Keywords: Body Dysmorphic Disorder, Dysmorphophobia, Cosmetic surgery, Aesthetic 
surgery, Dermatologic treatments 
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Introduction 
Body dysmorphic disorder (BDD) is a disabling mental health disorder characterised 1 
by a distressing and/or impairing preoccupation with a perceived defect in physical 2 
appearance. This is typically accompanied by time-consuming repetitive behaviours such as 3 
mirror checking or camouflaging the perceived defect(s) (American Psychiatric Association, 4 
2013). Epidemiological studies indicate that BDD affects between 0.7% to 2.4% of 5 
individuals in the general population (Buhlmann et al., 2010; Faravelli et al., 1997; Koran, 6 
Abujaode, Large, & Serpe, 2008; Otto, Wilhelm, Cohen, & Harlow, 2001; Rief, Buhlmann, 7 
Borkenhagen, & Brahler, 2006). BDD is associated with substantial psychiatric comorbidity 8 
(Pavan et al., 2008), poor quality of life (Didie et al., 2007) and high rates of suicidality 9 
(Phillips, Menard, Fay, & Weisberg, 2005).  10 
A high proportion of patients with BDD, around 76%, undergo cosmetic treatments, 11 
both surgical and minimally invasive treatments, in an attempt to ‘fix’ perceived defect/s in 12 
physical appearance (Crerand, Menard, & Phillips, 2010; Crerand, Phillips, Menard, & Fay, 13 
2005; Metcalfe et al., 2014; Phillips, Grant, Siniscalchi, & Albertini, 2001). Surgical 14 
treatments include operations such as rhinoplasty, breast augmentation, labiaplasty, 15 
implants and rhytidectomy. Minimally invasive treatments include dermatological procedures 16 
(e.g., chemical peels), dentistry work, electrolysis, collagen injections and mole removal. The 17 
prevalence rate of BDD across surgical and minimally invasive treatment settings is believed 18 
to be between 5% and 20% (Alavi, Kalafi, Dehbozorgi, & Javadpour, 2011; Crerand, 19 
Franklin, & Sarwer, 2006; Metcalfe et al., 2014; Pavan et al., 2006; Phillips, Dufresne, 20 
Wilkel, & Vittorio, 2000; Sarwer, Whitaker, Pertschuk, & Wadden, 1998; Veale, De Haro, & 21 
Lambrou, 2003; Vulink et al., 2006). For instance, up to 25% of individuals seeking 22 
rhinoplasty have been found to meet DSM-IV criteria for BDD (Alavi et al., 2011; 23 
Ghadakzadeh, Ghazipour, Khajeddin, Karimian, & Borhani, 2011; Veale et al., 2003; Vulink 24 
et al., 2008). Similarly high rates have been found in cosmetic, dermatological, and 25 
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orthodontic clinics, where 5%, 12%, and 10% of individuals endorse BDD symptomatology 26 
respectively (Phillips et al., 2000).  27 
BDD is a disorder of childhood with over 70% of cases reporting an onset prior to 18 28 
years of age (Bjornsson et al., 2013; Phillips & Diaz, 1997). Initial research suggests up to 29 
47% of young patients with BDD desire cosmetic treatment with around 33% receiving such 30 
interventions (Crerand et al., 2005; Mataix-Cols et al., 2015; Phillips et al., 2001). The 31 
psychological, legal and ethical considerations of performing cosmetic treatments on young 32 
people have previously been detailed (e.g., Crerand & Magee, 2013). The literature on 33 
cosmetic treatment for adults with BDD is limited, but the paucity of research is even more 34 
pronounced in relation to young people under 18.    35 
Outcomes of Cosmetic Treatments 36 
Despite the frequency with which individuals with BDD seek cosmetic treatments, few 37 
studies have examined the outcomes associated with such treatments in BDD. The overall 38 
message to practitioners to date has been that cosmetic interventions for individuals with 39 
BDD are detrimental (e.g., Crerand et al., 2006; Wilhelm, Phillips, & Steketee, 2013). 40 
Recently, however, increasing numbers of studies have provided preliminary evidence for 41 
positive outcomes in terms of satisfaction with procedure and reduction of BDD symptoms 42 
(Felix et al., 2014; Veale et al., 2014a). These findings have re-energised the debate as to 43 
whether the presence of BDD should be a contra-indication for cosmetic treatments (de Brito 44 
et al., 2015; de Brito, Nahas, & Ferreira, 2012; Felix et al., 2014; Morselli & Boriani, 2012). 45 
One side of the debate argues that cosmetic treatments are unlikely to address the 46 
underlying core symptomatology of BDD (e.g., Crerand et al., 2005, 2010; Phillips et al., 47 
2001), the other side claims that a selected group of individuals with BDD (e.g., individuals 48 
with mild to moderate BDD and with a single concern with realistic psychosocial 49 
expectations) might respond well to certain cosmetic treatments (e.g., Felix et al., 2014; 50 
Veale et al., 2003). Currently, mental health professionals are making recommendations 51 
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against cosmetic treatments for BDD but the evidence supporting these recommendations 52 
needs to be clear. 53 
Aim of Current Review 54 
The aim of the present article is to provide an up-to-date critical review of the literature 55 
on the outcomes of cosmetic treatments for individuals with BDD. Specifically, we aim to 56 
present and critique the breadth of outcomes that form the current debate and consider the 57 
clinical implications. Gaps in the current literature identified and future directions for research 58 
discussed.  59 
 60 
Method 61 
A literature search was conducted using EMBASE, Psychinfo, and MEDLINE. The 62 
inclusion criterion for this review were English-language articles on quantitative outcomes of 63 
cosmetic treatment for individuals diagnosed with or reasonably suspected to have BDD, 64 
with no other restriction. These were identified using the search terms ‘‘body dysmorphic 65 
disorder,’’ OR ‘‘dysmorphophobia,’’ OR “imagined ugliness,” OR “polysurgical addicts,” OR 66 
“insatiable patient,” AND ‘‘plastic surgery,’’ OR “cosmetic surgery,” OR “aesthetic treatment,” 67 
OR “aesthetic surgery,” OR “cosmetic treatment”. Reviews and studies assessing the 68 
prevalence of BDD, screening instruments, and/or other aspects not related to outcomes 69 
were excluded. As summarised in Table 1, a total of 11 peer-reviewed articles on pre- or 70 
post-cosmetic treatment outcomes for individuals with BDD or reasonably suspected BDD 71 
were identified. Two of these articles included a minority of young people. 72 
 73 
Results 74 
Negative Outcomes following Cosmetic Treatment in BDD  75 
 To date, the vast majority of studies suggest that cosmetic treatments for individuals 76 
with BDD are associated with poor outcomes (Crerand et al., 2005, 2010; Phillips & Diaz, 77 
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1997; Phillips et al., 2001; Picavet et al., 2013; Veale, 2000). Phillips and Diaz (1997) and 78 
Veale (2000) were among the first authors to systematically examine psychological 79 
outcomes for individuals with BDD who had received cosmetic treatments.  80 
Using a semi-structured interview of treatment history and the Clinical Global 81 
Impression Scale (CGI; Guy, 1976) to assess outcome of cosmetic interventions,  Phillips 82 
and Diaz (1997) asked 188 adults with BDD seeking psychological treatment about past 83 
cosmetic treatments (both surgical and minimally invasive interventions). The majority of 84 
patients (78% of women and 61% of men) reported their BDD symptoms to be unchanged or 85 
worsened following such procedures.  86 
Veale (2000) asked 25 patients with BDD who had received cosmetic treatment to 87 
rate their satisfaction and any changes in preoccupation, distress and functional impairment 88 
since the procedure. Self-report ratings using Likert scales, were consistently poor for the 89 
majority of respondents. For example, 31 out of total of 46 procedures (surgical and 90 
minimally invasive) resulted in satisfaction ratings of between 0-2.9 on an 11-point scale. 91 
The average rating for changes in preoccupation and handicap were 4.4 and 4.1 92 
respectively on a 7-point scale. However, outcomes varied according to the cosmetic 93 
procedure, with worse outcomes found for rhinoplasty and those receiving repeated 94 
operations. This finding raises the interesting question of whether certain cosmetic 95 
procedures are associated with better or worse outcomes for BDD. In line with this 96 
hypothesis, Crerand et al. (2010) found a trend for a more positive response to surgical 97 
interventions compared to minimally invasive interventions (e.g., chemical peels) in terms of 98 
preoccupation with the treated body part, but not for overall BDD symptomatology.  99 
Among the most widely-cited studies in this area are three large retrospective studies 100 
of between 200-289 patients with BDD, all of whom were seeking or receiving psychiatric 101 
care (Crerand et al., 2005, 2010; Phillips et al., 2001). These studies are the largest to date 102 
and two are the only studies currently that include outcomes for young people with BDD 103 
7 
 
 
 
(Crerand et al., 2005; Phillips et al., 2001). BDD diagnosis and severity were assessed using 104 
the Structured Clinical Interview for DSM-BDD Module (SCID-BDD; Phillips et al., 1995) the 105 
Yale-Brown Obsessive Compulsive Scale modified for BDD (YBOCS-BDD; Phillips et al., 106 
1997). Data on cosmetic treatments were obtained retrospectively using a semi-structured 107 
interview of treatment history, whilst treatment outcomes were assessed using the CGI. 108 
Specifically, patients were asked to rate the impact that the cosmetic intervention had on 109 
overall BDD symptoms and on the treated body part, on a scale from one (very much 110 
improved) to seven (very much worse). Consistently across these studies, CGI scores 111 
indicated that both surgical and minimally invasive cosmetic treatments, rarely resulted in 112 
improvements for adults or young people alike. For adults, in 72-91% of cases, the 113 
procedures led to no perceived change of BDD symptoms, and in 5.4-16.3% of cases, BDD 114 
symptoms deteriorated (Crerand et al., 2005; Phillips et al., 2001). In the later study by 115 
Crerand et al. (2010), 97.7% of adults receiving either surgical or minimally invasive 116 
procedures reported that there was no perceived change or a deterioration in BDD 117 
symptoms. Most individuals reported developing new appearance concerns, continuing to 118 
worry about the treated area (82.3%) and/or worrying that an improved body part would 119 
become ugly again (73.3%) (Crerand et al., 2005; Phillips et al., 2001). For young people, 120 
none of the cosmetic treatments received resulted in a reduction of the concern of the body 121 
part or the overall BDD symptom severity (Phillips et al., 2001). Treatments included 122 
minimally invasive procedures such as dermatology interventions and dentistry work as well 123 
as one instance of cosmetic surgery (procedure not specified).  124 
To date, there are just three prospective studies on cosmetic treatment outcomes for 125 
individuals with BDD that add weight to the findings that individuals with BDD do not tend to 126 
benefit from such procedures. In 2007, Tignol and colleagues compared outcomes of 127 
surgical procedures for a group of individuals with BDD (N = 10) and a group without (‘non-128 
BDD’; N = 14) in the first prospective study of this kind. The SCID-BDD (Phillips et al.,1995), 129 
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Mini International Neuropsychiatric Inventory (Sheehan, Harnett-Sheehan, & Raj, 1996), and 130 
the Sheehan Disability Scale (SDS) (Sheehan et al., 1996) were utilised to examine the 131 
impact of surgery on diagnosis, comorbidities, and BDD-related disability. There were no 132 
significant differences in satisfaction ratings between the two groups 5 years post-133 
operatively, with overall high satisfaction being reported (a rating of 4/5 for the BDD group 134 
and 4.4/5 for the non-BDD group, where 5 equalled ‘highly improved’). However, six out of 135 
the seven individuals with BDD who underwent surgery continued to meet DSM-IV criteria 136 
for the disorder following this. Relative to the group without BDD, individuals with BDD also 137 
endorsed significantly higher scores on the SDS following surgery, indicative of considerable 138 
BDD-related disability in spite of the intervention.  139 
In a second prospective study, Picavet et al. (2013) examined post-surgical 140 
outcomes for 166 individuals attending an Ear, Nose and Throat Clinic using the YBOCS-141 
BDD (Phillips et al., 1997), the SDS (Sheehan et al., 1996), and a one-item satisfaction 142 
questionnaire among other measures. Irrespective of any diagnosis, the authors note that 143 
scores on the YBOCS-BDD before surgery were inversely correlated with satisfaction and 144 
quality of life post-surgery, and positively correlated with appearance-related distress and 145 
impairment. By extrapolating the results to the BDD population, the authors suggest that the 146 
greater the severity of BDD symptoms initially, the poorer the outcomes of surgical 147 
procedures may be.  148 
Finally, among a sample of 728 individuals attending an oculofacial surgery clinic, 149 
Woolley and Perry (2015) found that those who scored above the cut-off for BDD on the 150 
Dysmorphic Concern Questionnaire (Oosthuizen, Lambert, & Castle, 1998) were more likely 151 
to endorse negative complications following their surgery. Indeed, these individuals 152 
experienced higher post-operative pain levels, greater complications, and higher re-153 
operation rates compared to those scoring below the cut-off. 154 
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 Taken together, these studies suggest that cosmetic treatments for those with BDD 155 
are generally associated with low levels of patient-reported satisfaction and overall poor 156 
outcomes (Crerand et al., 2005, 2010; Phillips & Diaz, 1997; Phillips et al., 2001; Picavet et 157 
al., 2013; Veale, 2000). The only prospective study using a standardised diagnostic 158 
instrument suggested that such procedures do not impact on BDD diagnosis (Tignol, 159 
Biraben-Gotzamanis, Martin-Geuhl, Grabot, & Aouizerate, 2007). However, results should 160 
be interpreted in light of a number of methodological shortcomings, most notably the largely 161 
retrospective nature of these studies as well as the sub-optimal diagnostic and assessment 162 
methods.  163 
The majority of these studies recruited individuals from psychiatric settings. Patients 164 
attending such clinics following cosmetic treatments may be more likely to have experienced 165 
‘surgery failures’ and may have more severe presentations of BDD.  Thus, there may be a 166 
recruitment bias in favour of cosmetic treatment failures in these studies (Crerand et al., 167 
2005; Phillips et al., 2001). Furthermore, surgical outcomes have been frequently assessed 168 
using single-item, self-reported scales of improvement in symptoms/appearance or 169 
satisfaction with the surgery (e.g., Crerand et al., 2005, 2010; Phillips & Diaz, 1997; Phillips 170 
et al., 2001; Veale, 2000). This method of assessment is dependent on the individual’s 171 
perception of improvement, as opposed to being based on an objective measurement. It is 172 
also subject to the individual’s recall and insight into their condition. Finally, without control 173 
comparison groups we cannot know how cosmetic treatment outcomes for BDD may differ 174 
from those for patients with other psychiatric disorders where such treatment is generally not 175 
discouraged. This is important to address given claims that pre-existing psychopathology or 176 
psychological problems predict outcomes in this area (Crerand, Infield, & Sarwer, 2007; von 177 
Soest, Kvalem, Skolleborg, & Roald, 2011; von Soest, Kvalem, & Wichstrøm, 2012).  178 
Positive Outcomes following Cosmetic Treatment in BDD  179 
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Recently, a small number of studies have provided data suggesting  that surgery 180 
may be helpful for a selected group of individuals with BDD (e.g., individuals with mild to 181 
moderate BDD or those receiving specific types of surgical interventions) (Felix et al., 2014; 182 
Veale et al., 2003, 2014a).  183 
 In the first study, Veale et al. (2003) identified 6 out of 29 individuals undergoing 184 
rhinoplasty as having “possible BDD” pre-surgery using the Body Dysmorphic Disorder 185 
Questionnaire (BDDQ; Phillips, Atala, & Pope, 1995). The BDDQ is a screening 186 
questionnaire involving four questions. Individuals were considered to have “possible BDD” if 187 
they answered ‘yes’ to both parts of question one, at least one option in question three and 188 
either of the last two options of question four. They all answered ‘no’ to question two 189 
regarding whether their main concern with appearance was that they might become too fat. 190 
Of these six individuals, one individual with BDD was lost to follow-up. Of the remaining five, 191 
three were classified as having “possible BDD” at 3 months post-surgery and none with 192 
“possible BDD” at 9 months post-surgery. Furthermore, the BDD and non-BDD groups were 193 
found to be equally satisfied with the outcome of rhinoplasty, as assessed using a one-item 194 
questionnaire on satisfaction.  195 
A similar pattern of findings was reported in a recent, larger study (Felix et al., 2014) 196 
in which 116 women seeking rhinoplasty were screened for BDD pre- and post- operatively, 197 
using the Body Dysmorphic Disorder Examination (BDDE; Rosen & Reiter, 1996). In total, 198 
31 women were classified as having mild-to-moderate BDD pre-surgery. Post-surgery and at 199 
1 year follow-up, this patient group reported satisfaction with the procedure (the authors 200 
however do not state how satisfaction was assessed in their study). The authors concluded 201 
that “individuals with mild to moderate BDD may benefit from rhinoplasty”. There are 202 
however, some serious methodological limitations with this study which are discussed 203 
below.  204 
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The third and final study suggesting positive outcomes for cosmetic surgery in BDD 205 
examined psychosexual outcomes following labiaplasty (Veale et al., 2014a). Individuals 206 
who scored above cut-off on the Cosmetic Procedure Screening for Labiaplasty (COPS-L; 207 
Veale et al., 2013) were then assessed for BDD using the SCID-BDD (Phillips et al., 1995). 208 
Nine out of 49 women seeking labiaplasty met diagnostic criteria for BDD pre-surgery. Eight 209 
were followed-up 3 months post-surgery, seven of whom achieved remission from BDD 210 
according to the SCID-BDD module. These individuals also reported satisfaction with the 211 
procedure in response to a ‘yes/no’ question. The authors suggest BDD may not be 212 
contraindicated for labiaplasty, at least in the short term. 213 
The interpretation of these positive findings must be considered within the context of 214 
a number of important methodological limitations. A major uncertainty emerging from the 215 
investigations cited above is whether the diagnosis of BDD could be confidently established. 216 
In particular, considerable methodological limitations related to diagnostic procedures limit 217 
the validity of findings by Felix et al. (2014). In their study, approximately half of the ‘BDD 218 
group’ (17/31) were considered to have a moderate to marked nasal deformity, an exclusion 219 
criteria for BDD. Also, whilst high remission rates were reported, it was unclear how 220 
remission was defined as all subjects spent at least one hour per day worrying about their 221 
defect at follow-up. This would be in line with a BDD diagnosis. Furthermore, the sample 222 
consisted of female participants only and it excluded individuals with severe BDD symptoms 223 
and those with overt avoidance behaviours, yet again challenging the diagnostic status and 224 
the representativeness of their BDD sample. This paper and its findings have been disputed 225 
within the field (e.g., Crerand & Phillips, 2014). 226 
The above studies have also not indicated whether individuals were receiving other 227 
(possibly psychiatric) treatment concomitant with surgery, and therefore it is not possible to 228 
determine to what extent improvements in BDD were a direct consequence of cosmetic 229 
interventions (Veale et al., 2003, 2014a). Finally, satisfaction ratings were typically obtained 230 
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using single-item questionnaires (e.g., Felix et al., 2014). Crerand et al. (2010) proposed that 231 
positive satisfaction ratings post cosmetic treatments are often time-limited, perhaps due to 232 
BDD being a chronic rather than episodic disorder. Surgery may help with one appearance 233 
concern but the person may develop new concerns with other features. This potentially 234 
provides an explanation for positive satisfaction ratings reported directly after an 235 
intervention.  236 
In light of these limitations, the evidence that some patients with BDD may achieve a 237 
reduction or remission of their symptoms following surgical treatment is preliminary and far 238 
from conclusive.  239 
 Adverse Events following Cosmetic Treatment in BDD  240 
There are a number of reports of relatively extreme adverse events following 241 
cosmetic treatments in individuals with BDD or suspected BDD. A handful of clinical reports, 242 
case series, and single case studies (including media reports) highlight violence and 243 
aggression perpetuated by patients with suspected BDD towards professionals, with at least 244 
four documented cases of surgeons murdered by individuals whose symptoms were 245 
consistent with a BDD diagnosis (Cotterill, 1996; Goin & Goin, 1986; Gorney, 2006; Ladee, 246 
1966; Leonardo, 2001; Lucas, 2002; McConnell, Lee, Black, & Shriver, 2015; Phillips, 247 
McElroy, & Lion, 1992; Phillips et al., 2001; Sarwer, 2002; Wright, 1987; Yazel, 1999). More 248 
recently, a case has been documented of a surgeon with suspected BDD who performed 249 
surgery on himself (Rafin, Pimstone, & Rapaport, 2011) and McConnell et al. (2015) 250 
describe how someone with suspected BDD committed suicide some years after being 251 
refused further surgical treatment.  252 
 It has been reported that occasionally patients with BDD will undergo several 253 
surgeries, with potentially irreversible outcomes (Veale, 2000). Others, in a desperate 254 
attempt to fix their perceived deformity or to ensure that they receive surgery, subject 255 
themselves to ‘self-surgery’, the consequences of which can be life-threatening (Phillips, 256 
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2005; Veale, 2000). Veale (2000) found that 9 out of 25 (36%) individuals with BDD 257 
attending a BDD clinic had performed “DIY surgery”, for example, stapling facial skin in an 258 
attempt to make it more taut.  259 
There have been documented cases of patients with BDD who have become suicidal 260 
following surgery (e.g., Phillips et al., 2001). However, the same large retrospective study 261 
found no overall difference in suicidal ideation or attempts between receivers and non-262 
receivers of cosmetic treatment. From a clinical perspective, having a cosmetic procedure 263 
may give hope to an individual with BDD and when this is not fulfilled, they may become 264 
more vulnerable and at risk of suicide. Of note, although these reports are widely cited in the 265 
field, most are post-hoc reports without assessment of BDD and as such, it cannot be 266 
determined whether these adverse outcomes were as a result of BDD, the cosmetic 267 
procedure, or other factors that were not assessed. 268 
Taken together, reports on extreme adverse outcomes highlight potentially life-269 
threatening complications for individuals with BDD undergoing cosmetic treatments and for 270 
professionals operating on them. Of note, however, the above outcomes are largely derived 271 
from case descriptions or studies where the diagnosis of individuals was not systematically 272 
assessed, limiting the conclusions that can be drawn. It is also possible that some of these 273 
outcomes (e.g., suicidality following surgery) reflect the nature and course of the disorder 274 
rather than being a direct consequence of cosmetic treatment. Nevertheless, the above 275 
reports highlight the need to be aware of self-surgery and the potentially negative outcomes 276 
(e.g., aggression, legal disputes, suicidality) that may occur when delivering cosmetic 277 
treatments to both adults and young people with BDD. 278 
 279 
Discussion 280 
In light of the recent debate, this review aimed to summarise the literature on 281 
outcomes for cosmetic treatment for individuals with BDD. A total of 11 studies (six 282 
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retrospective and five prospective studies) were reviewed, with variations in findings. On the 283 
whole, in spite of the paucity of research and the methodological limitations, the weight of 284 
the evidence thus far leans toward the conclusion that cosmetic treatment may be an 285 
ineffective intervention for the majority of individuals with BDD. This evidence is, however, 286 
largely based on retrospective studies looking at adult individuals’ recall of perceived 287 
outcomes, with the majority of individuals being recruited from psychiatric settings (Crerand 288 
et al., 2005, 2010; Phillips et al., 2001; Veale, 2000).  289 
Given the potential bias for surgery failures and more severe presentations of BDD in 290 
psychiatric settings, large prospective outcome studies are warranted, in which individuals 291 
with BDD from the general population (i.e., not in psychiatric care), including young people, 292 
are identified pre-cosmetic treatment and followed-up. Investigation of this kind would benefit 293 
from the use of standard diagnostic tools / instruments for the proper identification of BDD in 294 
individuals which would enable conclusions to be directly applicable to those with BDD. 295 
Future prospective studies should also aim to incorporate follow-up data to enable us to 296 
establish the stability of any changes to BDD severity/diagnosis following cosmetic 297 
treatments. Finally, previous investigations have largely assessed outcomes using single-298 
item self-report questionnaires on improvement or satisfaction, limiting our understanding of 299 
the impact of cosmetic treatment for BDD in all its facets. A broader range of outcome 300 
measures (e.g., measures of mood, suicidality quality of life) should be included in future 301 
studies.  302 
A few studies have implicated BDD severity, specific surgical interventions and 303 
location / area of concern as important factors influencing outcomes (Felix et al., 2014; 304 
Veale, 2000; Veale et al., 2003, 2014a). Future research should seek to replicate these 305 
findings and establish other demographic and clinical characteristics that may moderate 306 
outcome following cosmetic interventions in BDD. Candidate moderators include 307 
expectations of the patient, number of areas of concern, extent of preoccupation, and 308 
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psychiatric co-morbidity (Gorney, 2010). Given the difficulties with accurate diagnosis of 309 
BDD, relying solely on the BDD diagnosis may be too crude a predictor of poor outcome. 310 
The threshold for determining a ‘perceived or slight defect’, which is part of the current 311 
definition of BDD, has been raised as a potential pitfall in cosmetic settings. Specifically 312 
Picavet et al. (2013) suggest that judgement of a ‘slight defect’ by practitioners in such 313 
settings may end up excluding individuals from a BDD diagnosis with otherwise clear BDD 314 
symptomology.  315 
Considerations of Future Research 316 
Whilst there is a clear need for further, methodologically rigorous research on 317 
cosmetic procedures in BDD, research in this field raises a number of ethical dilemmas. In 318 
particular, one can question whether it is ethical to undertake a cosmetic procedure on an 319 
individual with BDD given the potential for a negative outcome. Despite their limitations, 320 
there are some studies we have cited here that point to the possibility of carrying out 321 
prospective work in this area (e.g., Tignol et al., 2007). The available literature also points to 322 
the fact that surgery is not the most frequently sought intervention although all of the 323 
prospective studies here were undertaken in a surgical setting. There may be more scope to 324 
conduct research within other cosmetic settings where minimally invasive treatments are 325 
completed. In either setting, research in this field would require careful risk management 326 
procedures.  327 
Finally, within Europe, there is an emphasis on patient involvement in research (e.g., 328 
Trivedi & Wykes, 2002). Patients with BDD not only desire cosmetic procedures, they also 329 
want credible evidence that such procedures could be ineffective. Utilising the viewpoint of 330 
those who have suffered with BDD to discuss the dilemmas raised here could be helpful. We 331 
hope these strategies may enable a continued focus on this research agenda in order to 332 
better inform and influence clinical practice.  333 
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Clinical Implications 334 
Although research regarding outcomes of cosmetic treatments for individuals with 335 
BDD is in its infancy, the findings reviewed here do have a number of important clinical 336 
implications.  337 
First, accurate detection and assessment of BDD in the medical / cosmetic arenas is 338 
clearly needed. A large survey of members of the American Society for Aesthetic Surgery 339 
and the American Society for Dermatologic Surgery illustrated that, the large majority of 340 
practitioners refuse to treat someone if they suspect BDD is present. However, the majority 341 
of surgeons (over 80%) reported not realising that they were treating a patient with BDD until 342 
after the surgery (Sarwer, 2002; Sarwer, Spitzer, Sobanko, & Beer, 2015). 343 
Recommendations for how practitioners in surgical and cosmetic settings might diagnose 344 
and manage patients with BDD are available (Crerand et al., 2006; Sarwer & Crerand, 345 
2008). A range of screening questionnaires are available for practitioners in both mental 346 
health and cosmetic settings to help aid successful diagnosis (Dey et al., 2015; Dufresne, 347 
Phillips, Vittorio, & Wilkel, 2001; Phillips et al., 1995; Veale et al., 2012).  348 
Accurate diagnosis is only one part of the problem however. Recent surveys suggest 349 
practitioners may not consider BDD a contraindication to cosmetic treatment (Sarwer, 2002; 350 
Sarwer et al., 2015). This highlights the need for mental health professionals to work closely 351 
with practitioners in cosmetic settings in order to raise awareness of BDD, facilitate accurate 352 
diagnosis, and increase awareness of the existing evidence regarding outcomes.  353 
Once BDD is identified, appropriate risk assessment by a mental health professional 354 
is essential and patients can be directed towards evidenced-based treatments, namely 355 
cognitive behaviour therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) 356 
(Krebs, Turner, Heyman, & Mataix-Cols, 2012; Mataix-Cols et al., 2015; Phillips & Hollander, 357 
2008; Veale et al., 2014b; Wilhelm et al., 2013). In line with national and international 358 
guidelines (e.g., National Institute for Health and Care Excellence; NICE, 2005), manuals 359 
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now exist with guidance on how to engage individuals with BDD in evidence-based 360 
treatment, taking into account their desire for cosmetic procedures (Wilhelm et al., 2013). 361 
In summary, there is a need to have increased detection and monitoring of BDD and 362 
plans for cosmetic treatment in both psychiatric and cosmetic fields with close liaison 363 
between professionals in order to complete appropriate screening and risk assessments. 364 
The need for professionals from cosmetic and psychiatric backgrounds to work together has 365 
been recommended before (e.g., Crerand et al., 2006; Sarwer & Spitzer, 2012). However as 366 
mentioned, recent surveys of practitioners in cosmetic settings suggest 40% still do not 367 
consider BDD a contraindication for cosmetic treatments (Sarwer et al., 2015). This 368 
suggests there is still much work to be done to translate the current research findings into 369 
changes within clinical practice.  370 
Conclusion 371 
The majority of adults and over 40% of young people with BDD seek and then 372 
receive cosmetic treatments. Although far from conclusive, the available evidence is 373 
suggestive of generally poor outcomes of cosmetic interventions in individuals with BDD. 374 
Further research is warranted to build robust evidence and shed further light on the debate 375 
as to whether BDD is a contraindication for cosmetic treatment. This information will better 376 
guide the recommendations practitioners give to individuals on the ground, especially in 377 
child and adolescent services where recommendations are currently being made on the 378 
basis of just two retrospective studies. In particular, prospective studies of well characterised 379 
individuals with BDD undergoing cosmetic procedures with long-term follow-up, using 380 
appropriate diagnostic and multidimensional outcome measures are required to determine 381 
the efficacy of cosmetic treatments for BDD and the patient-characteristics that influence 382 
outcomes. This information will enable the development of clinical guidelines and assist 383 
practitioners in giving BDD patients appropriate advice on cosmetic procedures. Finally, 384 
collaboration and education across mental health and cosmetic teams is paramount to 385 
18 
 
 
 
improve screening, identification, and treatment procedures for these highly distressed and 386 
vulnerable individuals.   387 
 388 
 389 
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Table 1  
 
Summary of Included Studies 
 
Type of Study SCID N Main Outcome Measure Setting Assessment Timing 
Retrospective      
    Phillips & Diaz, 1997 + 188 BDD 1-item improvement scale (CGI
a
) Psychiatric Post 
    Veale, 2000 + 25 BDD 1-item satisfaction scale (0-10), & change in preoccupation & 
handicap (0-7) 
Psychiatric Post 
    Phillips et al., 2001 + 289 BDD 
(39 YP
b
) 
1-item improvement scale (CGI) Psychiatric Post 
    Crerand et al., 2005 + 200 BDD 
 
1-item improvement scale (CGI) Psychiatric Post 
    Crerand et al., 2010 + 200 BDD 
(16 YP) 
1-item improvement scale (CGI) Psychiatric Post 
    Woolley & Perry, 2015 - 728 
(N = 50 ‘BDD’) 
Pain scores, No. re-operation & complications Oculofacial practice Post 
Prospective       
    Veale et al., 2003 - 29, (N = 6 ‘BDD’) 1-item satisfaction scale (0-8), BDDQ
c 
Private cosmetic clinics 
 
Pre-, 3, & 9 months post 
    Tignol et al., 2007 + 15, (N = 7 ‘BDD’) 1-item satisfaction scale (0-5), SCID-BDD
d
, 
Sheehan Disability Scale (SDS), MINI
e
, 
Cosmetic surgery clinic Pre- & 5 years post 
    Picavet et al., 2013 - 116, (N = 59 
‘BDD’) 
YBOCS-BDD-SR
f 
Ear, nose & throat dept. Pre-, 3, & 12 months post 
    Felix et al., 2014 - 31 ‘mild-mod BDD’ 1-item satisfaction scale, BDDE
g
, Time spent worrying University of São Paula Pre- & 1 year post 
    Veale et al., 2014a + 49 
(N = 9 BDD) 
Genital Appearance Satisfaction (0-33), SCID-BDD Private & NHS Clinics Pre-, 3, & 11-42 months post 
Note. 
a 
Clinical Global Impression Scale (Guy, 1976). 
b
 Young people. 
c 
Body Dysmorphic Disorder Questionnaire (Phillips, Atala, & Pope, 1995). 
d 
Structured Clinical 
Interview for DSM-IV BDD Module (Phillips et al., 1995). 
e 
Mini International Neuropsychiatric Inventory (Sheehan et al., 1996). 
f 
Yale-Brown Obsessive Compulsive 
Scale modified for BDD (Phillips et al., 1997). 
g 
Body Dysmorphic Disorder Examination (Rosen & Reiter, 1996).
 
 
